Should I buy or sell Bioceres Crop Solutions stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BIOX shares. View BIOX analyst ratings or view top-rated stocks .

What is Bioceres Crop Solutions' stock price target for 2024?

3 brokerages have issued 1-year price targets for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $15.00 to $25.00. On average, they expect the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price. View analysts price targets for BIOX or view top-rated stocks among Wall Street analysts .

How have BIOX shares performed in 2023?

Bioceres Crop Solutions' stock was trading at $12.03 at the beginning of the year. Since then, BIOX shares have increased by 2.7% and is now trading at $12.36. View the best growth stocks for 2023 here .

Are investors shorting Bioceres Crop Solutions?

Bioceres Crop Solutions saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 311,100 shares, an increase of 20.6% from the October 31st total of 257,900 shares. Based on an average daily volume of 65,700 shares, the short-interest ratio is presently 4.7 days. Currently, 1.0% of the company's shares are sold short. View Bioceres Crop Solutions' Short Interest .

When is Bioceres Crop Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024. View our BIOX earnings forecast .

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) posted its earnings results on Monday, September, 11th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.04 by $0.10. The business earned $104.70 million during the quarter, compared to analysts' expectations of $96.59 million. Bioceres Crop Solutions had a net margin of 2.71% and a trailing twelve-month return on equity of 3.40%. During the same quarter in the previous year, the company posted ($0.12) earnings per share.

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA) , ChromaDex (CDXC) , Trevena (TRVN) , Advanced Micro Devices (AMD) , Amyris (AMRS) , Celldex Therapeutics (CLDX) , Chimerix (CMRX) , CTI BioPharma (CTIC) .

When did Bioceres Crop Solutions IPO?

(BIOX) raised $130 million in an initial public offering (IPO) on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Ballast Asset Management LP (0.31%), Polar Capital Holdings Plc (0.30%), Federated Hermes Inc. (0.22%), Albert D Mason Inc. (0.11%), Oak Family Advisors LLC (0.10%) and Toroso Investments LLC (0.09%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Bioceres Crop Solutions Stock Price, News & Analysis (NASDAQ:BIOX)

$12.36

+0.16 (+1.31%)

(As of 12/1/2023 ET)

Compare

Today's Range: $12.04
▼
$12.39
50-Day Range: $10.33
▼
$12.36
52-Week Range: $9.76
▼
$14.20

Volume: 205,379 shs
Average Volume: 95,483 shs
Market Capitalization: $776.21 million

P/E Ratio: 68.67
Dividend Yield: N/A
Price Target: $20.00

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 61.8% Upside
$20.00 Price Target
Short Interest: Bearish
1.04% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.44
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 46.58%
From $0.73 to $1.07 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Consumer Staples Sector

54th out of 118 stocks

Agricultural Chemicals Industry

4th out of 9 stocks

3.5

Analyst's Opinion

Consensus Rating
Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $20.00, Bioceres Crop Solutions has a forecasted upside of 61.8% from its current price of $12.36.
Amount of Analyst Coverage
Bioceres Crop Solutions has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.04% of the float of Bioceres Crop Solutions has been sold short.
Short Interest Ratio / Days to Cover
Bioceres Crop Solutions has a short interest ratio ("days to cover") of 4.7.
Change versus previous month
Short interest in Bioceres Crop Solutions has recently increased by 20.63%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Bioceres Crop Solutions does not currently pay a dividend.
Dividend Growth
Bioceres Crop Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BIOX.

3.0

News and Social Media Coverage

News Sentiment
Bioceres Crop Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Bioceres Crop Solutions this week, compared to 0 articles on an average week.
Search Interest
3 people have searched for BIOX on MarketBeat in the last 30 days.
MarketBeat Follows
2 people have added Bioceres Crop Solutions to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.
Percentage Held by Institutions
Only 13.35% of the stock of Bioceres Crop Solutions is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Bioceres Crop Solutions are expected to grow by 46.58% in the coming year, from $0.73 to $1.07 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bioceres Crop Solutions is 68.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 109.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bioceres Crop Solutions is 68.67, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.37.
Price to Book Value per Share Ratio
Bioceres Crop Solutions has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIOX Stock News Headlines

November 30, 2023 | americanbankingnews.com

Head to Head Comparison: China Agri-Business (OTCMKTS:CHBU) and Bioceres Crop Solutions (NASDAQ:BIOX)

November 14, 2023 | seekingalpha.com

Bioceres Crop Solutions Corp. 2024 Q1 - Results - Earnings Call Presentation

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 12, 2023 | benzinga.com

Earnings Outlook For Bioceres Crop Solutions

November 1, 2023 | morningstar.com

Bioceres Crop Solutions Corp BIOX

November 1, 2023 | markets.businessinsider.com

Roth MKM Maintains Buy Rating for Bioceres Crop Solutions: Here's What You Need To Know

October 23, 2023 | finance.yahoo.com

Bioceres Crop Solutions Corp. (KYG1117K1141.SG)

October 13, 2023 | markets.businessinsider.com

Analysts Offer Insights on Industrial Goods Companies: Bioceres Crop Solutions (BIOX) and Bowman Consulting Group (BWMN)

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

October 13, 2023 | markets.businessinsider.com

Bioceres Crop Solutions’ Solid Long-Term Outlook Overshadows Current Challenges: An Analysis of the HB4 Program and Strategic Partnerships

September 13, 2023 | insidermonkey.com

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Q4 2023 Earnings Call Transcript

September 12, 2023 | seekingalpha.com

Bioceres Crop Solutions shares fall as weather-related headwinds hit sales

September 12, 2023 | msn.com

Roth MKM Reiterates Bioceres Crop Solutions (BIOX) Buy Recommendation

September 12, 2023 | msn.com

Lake Street Maintains Bioceres Crop Solutions (BIOX) Buy Recommendation

September 12, 2023 | seekingalpha.com

Bioceres Crop Solutions' HB4 Technology: A Game Changer

September 11, 2023 | seekingalpha.com

Bioceres Crop Solutions Corp. 2023 Q4 - Results - Earnings Call Presentation

August 10, 2023 | finance.yahoo.com

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

July 19, 2023 | msn.com

Corteva (CTVA) & Bioceres to Drive Bio Solutions in Europe

June 17, 2023 | msn.com

Bioceres Crop Solutions: Worrying Amounts Of Share Dilution Here

May 12, 2023 | markets.businessinsider.com

Lake Street Keeps Their Buy Rating on Bioceres Crop Solutions (BIOX)

May 5, 2023 | fool.com

Bioceres Crop Solutions (NASDAQ: BIOX)

April 17, 2023 | finance.yahoo.com

With Bioceres Crop Solutions Corp. (NASDAQ:BIOX) It Looks Like You'll Get What You Pay For

April 6, 2023 | msn.com

Oppenheimer Initiates Coverage of Bioceres Crop Solutions (BIOX) with Outperform Recommendation

March 16, 2023 | reuters.com

Indonesia Oks GMO drought-tolerant wheat from Argentina's Bioceres

March 3, 2023 | finance.yahoo.com

Bioceres Crop Solutions Announces Brazil´s Regulatory Approval of Drought Tolerant HB4® Wheat for Commercialization and Cultivation

February 26, 2023 | nypost.com

Courteney Cox slays dressing like ‘Gen-Z girls’ in crop top, baggy jeans

January 26, 2023 | finance.yahoo.com

Bioceres Crop Solutions to Host Fiscal Second Quarter 2023 Financial Results Conference Call on Thursday, February 9, 2023 at 8:30 a.m. Eastern Time

See More Headlines

Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/11/2023
Today: 12/03/2023
Next Earnings (Estimated): 2/14/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Agricultural chemicals
Sub-Industry: N/A
Sector: Consumer Staples
Current Symbol: NASDAQ:BIOX
CUSIP: N/A
CIK: 1769484
Web: biocerescrops.com
Phone: 543414861100
Fax: N/A
Employees: 447
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $20.00
High Stock Price Target: $25.00
Low Stock Price Target: $15.00
Potential Upside/Downside: +61.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.18
Trailing P/E Ratio: 68.67
Forward P/E Ratio: 16.93
P/E Growth: N/A
Net Income: $18.78 million
Net Margins: 2.71%
Pretax Margin: 1.94%
Return on Equity: 3.40%
Return on Assets: 1.32%

Debt

Debt-to-Equity Ratio: 0.38
Current Ratio: 1.27
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $419.80 million
Price / Sales: 1.85
Cash Flow: $0.57 per share
Price / Cash Flow: 21.51
Book Value: $5.30 per share
Price / Book: 2.33

Miscellaneous

Outstanding Shares: 62,800,000
Free Float: 61,346,000
Market Cap: $776.21 million
Optionable: Not Optionable
Beta: 0.48

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Jose A. Roque
General Counsel
Alex Garcia
Managing Director of Seeds
Dr. Federico Trucco Ph.D. (Age 46)
Chairman & CEO
Comp: $131.16k
Mr. Enrique López Lecube (Age 41)
CFO & Executive Director
Comp: $129.89k
Mr. Jorge Wagner (Age 54)
Chief Operating Officer
Comp: $165.6k
Ms. Paula Savanti
Head of Investor Relations
Mr. Ricardo Luis Yapur (Age 65)
Managing Director of Latam Unit & Chief Commercial Officer
Comp: $260k
Mr. Matti Tiainen (Age 33)
Managing Director of North America & Europe

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BIOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bioceres Crop Solutions stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BIOX shares.
View BIOX analyst ratings or view top-rated stocks.
What is Bioceres Crop Solutions' stock price target for 2024?: 3 brokerages have issued 1-year price targets for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $15.00 to $25.00. On average, they expect the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for BIOX or view top-rated stocks among Wall Street analysts.
How have BIOX shares performed in 2023?: Bioceres Crop Solutions' stock was trading at $12.03 at the beginning of the year. Since then, BIOX shares have increased by 2.7% and is now trading at $12.36.
View the best growth stocks for 2023 here.
Are investors shorting Bioceres Crop Solutions?: Bioceres Crop Solutions saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 311,100 shares, an increase of 20.6% from the October 31st total of 257,900 shares. Based on an average daily volume of 65,700 shares, the short-interest ratio is presently 4.7 days. Currently, 1.0% of the company's shares are sold short.
View Bioceres Crop Solutions' Short Interest.
When is Bioceres Crop Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our BIOX earnings forecast.
How were Bioceres Crop Solutions' earnings last quarter?: Bioceres Crop Solutions Corp. (NASDAQ:BIOX) posted its earnings results on Monday, September, 11th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.04 by $0.10. The business earned $104.70 million during the quarter, compared to analysts' expectations of $96.59 million. Bioceres Crop Solutions had a net margin of 2.71% and a trailing twelve-month return on equity of 3.40%. During the same quarter in the previous year, the company posted ($0.12) earnings per share.

What other stocks do shareholders of Bioceres Crop Solutions own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS), Celldex Therapeutics (CLDX), Chimerix (CMRX), CTI BioPharma (CTIC).
When did Bioceres Crop Solutions IPO?: (BIOX) raised $130 million in an initial public offering (IPO) on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.
Who are Bioceres Crop Solutions' major shareholders?: Bioceres Crop Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Ballast Asset Management LP (0.31%), Polar Capital Holdings Plc (0.30%), Federated Hermes Inc. (0.22%), Albert D Mason Inc. (0.11%), Oak Family Advisors LLC (0.10%) and Toroso Investments LLC (0.09%).
How do I buy shares of Bioceres Crop Solutions?: Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BIOX) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial